About: Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 14 June 2011

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) наукова стаття, опублікована в червні 2011 (uk) scientific article published on 14 June 2011 (en) مقالة علمية نشرت في 14 يونيو 2011 (ar) artículu científicu espublizáu en xunu de 2011 (ast)
publication date	wds:Q37889842-13AE642E-C59C-43FA-AF63-1A37CD329830
publication date	2011-06-14 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37889842-7EB72F6B-A220-4365-BD9C-3BE4E46E3C41
language of work or name	English
cites work	wds:Q37889842-397FEC42-45F0-4D3A-887E-896F35C307F6 wds:Q37889842-410B3E4B-FDA8-4D1E-8CC7-5176157776BC wds:Q37889842-600C7839-EC7B-4980-9967-7DFFD80A8216 wds:Q37889842-6B341FC0-9BF8-425C-A05F-AFBF39F0A382 wds:Q37889842-9AEC8294-AE15-4FF8-B7A8-A582E0AE370C wds:Q37889842-B8B032AC-5EAD-4361-B8FA-827D2B6BE3B7 wds:Q37889842-C3390222-FB07-4C87-AE51-4054BD483701 wds:Q37889842-C740CA3A-31C2-4132-9F29-22EE76861316 wds:Q37889842-E5D80EC1-E39C-43E5-B940-C2FB42ECF1E8 wds:Q37889842-F5DBECCA-F791-4688-9F90-27283948833F
cites work	Randomised controlled trial of azathioprine withdrawal in ulcerative colitis Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort.
author name string	wds:Q37889842-15768A18-1814-4742-BAAA-16187F539BF5 wds:Q37889842-B36F8F9C-32BE-4861-8F2D-8F63E739599E
author name string	Miguel Regueiro Kofi Clarke
rdfs:label	Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission (en) Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission (nl)
skos:prefLabel	Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission (en) Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission (nl)
name	Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission (en) Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission (nl)
title	wds:Q37889842-02E41A70-87D1-4434-A33C-23BFF2C216FA
title	Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission (en)
page(s)	wds:Q37889842-D21621F8-8E19-4BD9-AC3F-D0D55E3E6634
page(s)	174-179
instance of	wds:Q37889842-15B4B3FE-4000-4866-98EE-FF42AD17DD94 wds:Q37889842-8d5b9e59-08bc-4ca6-9037-c42d82ab41e8
instance of	review article scholarly article
main subject	wds:Q37889842-2387FEEF-5AB4-4021-9D1F-AD323C814B78 wds:Q37889842-DD1B10B8-C1D3-4616-902D-85F40808D070
main subject	inflammation inflammatory bowel diseases
PubMed ID	wds:Q37889842-6D19C390-0227-44BA-AF2E-2180F4D7C08D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21674731
PubMed ID	21674731
published in	wds:Q37889842-0970EDEB-453F-43DA-B18D-96CE072821E3
published in	Inflammatory Bowel Diseases
issue	wds:Q37889842-76308684-495C-40C7-9B59-E4536CBDEBD7
volume	wds:Q37889842-D3923AA6-8730-4CAA-B058-51035C32D35A
issue	1
volume	18
DOI	wds:Q37889842-75FB49F3-5DEF-4D3E-A283-D034FBA687E0
DOI	http://dx.doi.org/10.1002/IBD.21792
DOI	10.1002/IBD.21792
ResearchGate publication ID	wds:Q37889842-16046EA3-1460-4E86-AA8F-DAF128CF0051
ResearchGate publication ID	51220699
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q37889842
is cites work of	Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal. Achievement of deep remission during scheduled maintenance therapy with TNFα-blocking agents in IBD. Use of thiopurines in inflammatory bowel disease Histological healing in inflammatory bowel disease: a still unfulfilled promise Dysregulation of anti-inflammatory annexin A1 expression in progressive Crohns Disease Recent advances using immunomodulators for inflammatory bowel disease Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study. The role and advances of immunomodulator therapy for inflammatory bowel disease Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy. The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study. How I treat my inflammatory bowel disease-patients with thiopurines? Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ('Exit Strategies') in Inflammatory Bowel Disease. Management of Inflammatory Bowel Disease in the Elderly Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level. Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy? Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy. Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies. Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software